JP Morgan Private Wealth Advisors’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,352
Closed -$246K 1981
2022
Q4
$246K Sell
3,352
-42
-1% -$3.16K ﹤0.01% 1734
2022
Q3
$258K Buy
3,394
+298
+10% +$23.2K ﹤0.01% 1720
2022
Q2
$215K Buy
3,096
+80
+3% +$6.03K ﹤0.01% 1794
2022
Q1
$250K Sell
3,016
-766
-20% -$56.4K ﹤0.01% 1830
2021
Q4
$284K Buy
3,782
+53
+1% +$5.32K ﹤0.01% 1764
2021
Q3
$433K Buy
3,729
+250
+7% +$37.8K ﹤0.01% 1556
2021
Q2
$772K Buy
3,479
+1,854
+114% +$361K ﹤0.01% 1316
2021
Q1
$215K Sell
1,625
-2,347
-59% -$371K ﹤0.01% 1657
2020
Q4
$687K Buy
+3,972
New +$544K ﹤0.01% 1154
2020
Q2
Sell
-3,702
Closed -$249K 1584
2020
Q1
$249K Sell
3,702
-1,250
-25% -$98.8K ﹤0.01% 1201
2019
Q4
$417K Buy
4,952
+300
+6% +$24.2K ﹤0.01% 1115
2019
Q3
$348K Buy
+4,652
New +$372K ﹤0.01% 1134
2019
Q2
Sell
-16,800
Closed -$809K 1440
2019
Q1
$809K Buy
+16,800
New +$809K ﹤0.01% 862
2018
Q4
Sell
-30,700
Closed -$1.61M 1548
2018
Q3
$1.61M Buy
+30,700
New +$1.22M 0.01% 675

Other funds holding NVCR

JP Morgan Private Wealth Advisors's NVCR Position: Q1 2023 in Review

JP Morgan Private Wealth Advisors sold out of NovoCure (NVCR) in Q1 2023, closing a stake of 3,352 shares — an estimated $246K sold.

JP Morgan Private Wealth Advisors first reported a position in NVCR in Q3 2018 and held it in 14 quarters. The position peaked at $1.61M in Q3 2018. 295 funds tracked by Wall St. Rank hold NVCR as of Q1 2023.

  • JP Morgan Private Wealth Advisors reported no remaining NovoCure position as of Q1 2023 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 3,352 NovoCure shares in Q1 2023, an estimated $246K.
  • JP Morgan Private Wealth Advisors first reported a position in NovoCure in Q3 2018 and held it in 14 quarters.
  • JP Morgan Private Wealth Advisors's NovoCure position peaked at $1.61M in Q3 2018.
  • 295 funds tracked by Wall St. Rank held NovoCure as of Q1 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2023, filed 12 May 2023.